| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/07/2011 | US7956254 Plants and seeds of hybrid corn variety CH651588 |
| 06/07/2011 | US7956253 Plants and seeds of hybrid corn variety CH475849 |
| 06/07/2011 | US7956252 Plants and seeds of hybrid corn variety CH482178 |
| 06/07/2011 | US7956251 Plants and seeds of hybrid corn variety CH347605 |
| 06/07/2011 | US7956250 Plants and seeds of hybrid corn variety CH038350 |
| 06/07/2011 | US7956249 Plants and seeds of hybrid corn variety CH147656 |
| 06/07/2011 | US7956248 Plants and seeds of hybrid corn variety CH309839 |
| 06/07/2011 | US7956247 Plants and seeds of hybrid corn variety CH421690 |
| 06/07/2011 | US7956245 Soybean variety RJS53001 |
| 06/07/2011 | US7956244 Soybean variety RJS25004 |
| 06/07/2011 | US7956241 Plant having enhanced root elongation and method for production thereof |
| 06/07/2011 | US7956240 Plants having improved growth characteristics and method for making the same |
| 06/07/2011 | US7956238 Porcine pancreatic amylase gene promoter and transgenic pigs expressing heterologous digestive enzymes |
| 06/07/2011 | US7956177 dsRNA compositions and methods for treating HPV infection |
| 06/07/2011 | US7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 06/07/2011 | US7956174 Constitutive promoters from poplar and uses thereof |
| 06/07/2011 | US7956172 Fluorescent protein and chromoprotein |
| 06/07/2011 | US7956043 oligonucleotides having a '5TCG motif without any additional unmethylated CpG motifs have strong immunostimulatory capability |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/07/2011 | US7956036 Polypeptide and DNA thereof useful as a neovascular marker |
| 06/07/2011 | US7956034 FSH mutant with increased glycosylation and longer half-life; for inducing folliculogenesis in human; treating an infertile mammal |
| 06/07/2011 | US7955849 Method of enriching a mammalian cell population for mesoderm cells |
| 06/07/2011 | US7955848 MicroRNA biomarkers for human breast and lung cancer |
| 06/07/2011 | US7955845 Transgenic cells comprising enhanced immune response for use in treatment of infections, cancers and pathologies associated with transplantation |
| 06/07/2011 | US7955844 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals |
| 06/07/2011 | US7955832 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells |
| 06/07/2011 | US7955828 Use of methionine synthase inhibitors for the treatment of fungal diseases of crops |
| 06/07/2011 | US7955827 Controlled electroporation and mass transfer across cell membranes |
| 06/07/2011 | US7955821 Nucleic acid encoding a self-assembling split-fluorescent protein system |
| 06/07/2011 | US7955808 Bitter taste receptors |
| 06/07/2011 | US7955796 Identifying nucleotide sequences polymorphisms and/orvariations between methicillin resistant and sensitive bacteria; diagnosis and treatment of infection; using polymorphic sequences to distinguish between bacterial phenotypes; genomics |
| 06/07/2011 | US7955638 Surface for the immobilization of ligands |
| 06/07/2011 | US7955600 Attenuated salmonella SP12 mutants as antigen carriers |
| 06/07/2011 | US7955597 Anti-IL-6 antibodies, compositions, methods and uses |
| 06/07/2011 | US7955596 B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 06/07/2011 | US7955595 Glutamic acid decarboxylase (GAD) based delivery system |
| 06/07/2011 | US7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2442971C Chemotherapeutic induction of egr-1 promoter activity |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2441436C Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 06/07/2011 | CA2435685C Desaturase genes and uses thereof |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2406232C Plants containing a cytosolic acetyl coa-carboxylase nucleic acid |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2400993C Carriers coated with polysaccharides, their preparation and use |
| 06/07/2011 | CA2378866C Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2355574C Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
| 06/07/2011 | CA2349838C Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 06/07/2011 | CA2339967C Structural analogs of amine bases and nucleosides |
| 06/07/2011 | CA2321226C Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 06/07/2011 | CA2232245C Cellulases, the genes encoding them and uses thereof |
| 06/07/2011 | CA2230556C Novel procollagens |
| 06/07/2011 | CA2187083C Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/07/2011 | CA2165949C Tuberculosis vaccine |
| 06/03/2011 | WO2011066578A1 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer |
| 06/03/2011 | WO2011066571A2 Assays for mutagenesis detection |
| 06/03/2011 | WO2011066541A2 Biological circuit chemotactic converters |
| 06/03/2011 | WO2011066475A1 Sirna compounds comprising terminal substitutions |
| 06/03/2011 | WO2011066467A2 Allelic ladder loci |
| 06/03/2011 | WO2011066458A2 Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| 06/03/2011 | WO2011066372A2 Citrullination of human peptidylarginine deiminase 4 (pad-4) regulates its function and immunogenicity |
| 06/03/2011 | WO2011066360A1 Detection of aad-12 soybean event 416 |
| 06/03/2011 | WO2011066330A2 Selective amplification of polynucleotide sequences |
| 06/03/2011 | WO2011066312A1 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 06/03/2011 | WO2011066304A2 Engineered beta-class carbonic anhydrase polypeptides and uses thereof |
| 06/03/2011 | WO2011066008A2 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
| 06/03/2011 | WO2011065935A1 Methods for monoclonal antibody production |
| 06/03/2011 | WO2011065715A2 Method of preparing cells susceptible to transmissible spongiform encephalopathy and the creation of tse persistently infected cells |
| 06/03/2011 | WO2011065539A1 Process for production of ethanol from biomass |
| 06/03/2011 | WO2011065469A1 L-cysteine-producing bacterium, and process for production of l-cysteine |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011065168A1 Method and apparatus for prediction of pharmacological efficacy of humanized anti-tnfα antibody drug on rheumatoid arthritis |
| 06/03/2011 | WO2011064758A2 Fusion protein |
| 06/03/2011 | WO2011064751A1 Chimeric endonucleases and uses thereof |
| 06/03/2011 | WO2011064750A1 Chimeric endonucleases and uses thereof |
| 06/03/2011 | WO2011064736A1 Optimized endonucleases and uses thereof |
| 06/03/2011 | WO2011064437A2 Viral vectors and methods used in the preparation of gdnf |
| 06/03/2011 | WO2011064395A2 Inhibitors and antagonists of calcium channels in the treatment of asthma |
| 06/03/2011 | WO2011064354A2 Micro-rna and tissue repair |
| 06/03/2011 | WO2011064282A1 Method for making polypeptides |
| 06/03/2011 | WO2011064262A1 Conditional expression of transgenes in vivo |
| 06/03/2011 | WO2011064224A1 Banana promoters |
| 06/03/2011 | WO2011064183A1 Novel fatty acid elongase and uses thereof |
| 06/03/2011 | WO2011064181A1 Novel fatty acid desaturase and uses thereof |
| 06/03/2011 | WO2011064130A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation |
| 06/03/2011 | WO2011063921A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
| 06/03/2011 | WO2011063707A1 Dehydrin-like gene of cotton and uses thereof |
| 06/03/2011 | WO2011063706A1 Gene of cotton transcription factor nac and use thereof |
| 06/03/2011 | WO2011063660A1 Optimized flagellin protein, preparation method and use thereof |
| 06/03/2011 | WO2011063523A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/03/2011 | WO2011031319A8 Rnai in budding yeast |
| 06/03/2011 | WO2011025717A3 Promoter system for regulatable gene expression in mammalian cells |
| 06/03/2011 | WO2011017691A3 Enhanced molecular detection of targeted intracellular mrna transcription using polynucleotide functionalized nanoparticles |
| 06/03/2011 | WO2011017315A3 Methods and compositions for targeted gene modification |
| 06/03/2011 | WO2011014693A3 Bacteriophages expressing amyloid peptides and uses thereof |
| 06/03/2011 | WO2011011674A3 Production of erythropoiesis stimulating protein using metal ions |
| 06/03/2011 | WO2011011568A3 Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms |
| 06/03/2011 | WO2010147673A3 Single-dna molecule nanomotor regulated by photons |
| 06/03/2011 | WO2010140834A3 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |